NCT04049955

Brief Summary

Obesity is a major health problem in western countries, and sleeve gastrectomy has proven its effectiveness on weight loss and improvement of comorbidities related to obesity. The main complication is the occurrence of upper fistula (2%), and may be responsible of several deaths. There is no consensus on medical, radiological and surgical management of fistula. It depends on the resources of each center and is based on a low level evidence The inconstant efficacy of the endoscopic treatment by closing fistula (digestive stents, clips, glue) motivates a new endoscopic approach. It consists of an internal drainage of the collection by using double pigtail stents through the fistulous orifice.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Aug 2019

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 18, 2019

Completed
14 days until next milestone

Study Start

First participant enrolled

August 1, 2019

Completed
7 days until next milestone

First Posted

Study publicly available on registry

August 8, 2019

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2021

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2021

Completed
Last Updated

January 18, 2023

Status Verified

January 1, 2023

Enrollment Period

1.9 years

First QC Date

July 18, 2019

Last Update Submit

January 17, 2023

Conditions

Keywords

sleeve gastrostomyendoscopyfistuladouble pig tail stents

Outcome Measures

Primary Outcomes (1)

  • Number of Participants with Fistula Healing at week 18

    Number of Participants with Healing at week 18

    week 18 after endoscopy

Secondary Outcomes (5)

  • Number of Participants with Fistula Healing at week 6

    week 6 after endoscopy

  • Number of Participants with Fistula Healing at week 12

    week 12 after endoscopy

  • Number of Participants with Fistula delay

    up to week 18 after endoscopy

  • Number of Participants with gastric stenosis

    up to week 18 after endoscopy

  • Measure of length of hospital stay

    up to week 18 after endoscopy

Study Arms (1)

endoscopy

EXPERIMENTAL

In the case of a well-organized abscessed collection responsible for sepsis instability, or poorly organized collection, an external drainage is carried out, by a radiological or a surgical way. The endoscopy is performed 7 days later. If there is no hemodynamic instability and in presence of a well-organized abscessed collection, a first-line endoscopy is carried out. After laying 2 double pig tail stents, the external drainage is removed 2 to 7 days later.

Procedure: endoscopy

Interventions

endoscopyPROCEDURE

In the case of a well-organized abscessed collection responsible for sepsis instability, or poorly organized collection, an external drainage is carried out, by a radiological or a surgical way. The endoscopy is performed 7 days later. If there is no hemodynamic instability and in presence of a well-organized abscessed collection, a first-line endoscopy is carried out. After laying 2 double pig tail stents, the external drainage is removed 2 to 7 days later.

endoscopy

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may not qualify if:

  • Free, informed and signed consent
  • Affiliation to the social security system
  • Other surgery than Sleeve gastrectomy
  • Fistula located at a site other than the upper pole of the staple line
  • Fistulization on the upper diaphragmatic floor
  • Fistulous orifice larger than 25 mm
  • Pregnancy
  • Patient under guardianship or curators or deprived of public law

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Centre Hospitalier Universitaire d'Amiens

Amiens, Picardie, 80000, France

Location

MeSH Terms

Conditions

Fistula

Interventions

Endoscopy

Condition Hierarchy (Ancestors)

Pathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Diagnostic Techniques, SurgicalDiagnostic Techniques and ProceduresDiagnosisMinimally Invasive Surgical ProceduresSurgical Procedures, Operative

Study Officials

  • Sami Hakim, MD

    CHU Amiens

    PRINCIPAL INVESTIGATOR
  • Jean-Marc Regimbeau, Pr

    CHU Amiens

    PRINCIPAL INVESTIGATOR
  • Lionel Rebibo, MD

    Hopital Bichat, Paris

    PRINCIPAL INVESTIGATOR
  • Jean-Christophe Duchmann, MD

    Centre Hospitalier Compiègne

    PRINCIPAL INVESTIGATOR
  • Jonathan Levy, MD

    Clinique des Cèdres Chât Alliez, Cornebarrieu

    PRINCIPAL INVESTIGATOR
  • Jean-François Bourgaux, MD

    CHRU Nimes

    PRINCIPAL INVESTIGATOR
  • Ion Donici, MD

    CHRU Nimes

    PRINCIPAL INVESTIGATOR
  • Vincent Quentin, MD

    CH Saint Brieux

    PRINCIPAL INVESTIGATOR
  • Fabien Fumex, MD

    Hopital Jean Mermoz, Lyon

    PRINCIPAL INVESTIGATOR
  • Gaetan Singier, MD

    Hopital Jean Mermoz, Lyon

    PRINCIPAL INVESTIGATOR
  • Cécile Gomercic, MD

    CHU NICE

    PRINCIPAL INVESTIGATOR
  • Antonio Iannelli, MD

    CHU NICE

    PRINCIPAL INVESTIGATOR
  • Claire Blanchard, MD

    Nantes University Hospital

    PRINCIPAL INVESTIGATOR
  • Timothée Wallenhorst, MD

    CHU Rennes

    PRINCIPAL INVESTIGATOR
  • Damien Bergeat, MD

    CHU Rennes

    PRINCIPAL INVESTIGATOR
  • Davide Mazza, MD

    CH TOULON

    PRINCIPAL INVESTIGATOR
  • Stéphane Koch, MD

    CHRU Besançon

    PRINCIPAL INVESTIGATOR
  • Nicolas Bouviez, MD

    CHRU Besançon

    PRINCIPAL INVESTIGATOR
  • Antoine Soprani, MD

    Clinique Paris-Bercy

    PRINCIPAL INVESTIGATOR
  • Clément Subtil, MD

    University Hospital, Bordeaux

    PRINCIPAL INVESTIGATOR
  • Ulriikka Chaput, MD

    Hopital Saint Antoine, Paris

    PRINCIPAL INVESTIGATOR
  • Jérome Rivory, MD

    Hopital Edouard Herriot - Lyon

    PRINCIPAL INVESTIGATOR
  • Maud Robert, MD

    Hopital Edouard Herriot - Lyon

    PRINCIPAL INVESTIGATOR
  • Franck Cholet, MD

    CHU Brest

    PRINCIPAL INVESTIGATOR
  • Jérémie Thereaux, MD

    CHU Brest

    PRINCIPAL INVESTIGATOR
  • Jean-Christophe Valats, MD

    University Hospital, Montpellier

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 18, 2019

First Posted

August 8, 2019

Study Start

August 1, 2019

Primary Completion

July 1, 2021

Study Completion

November 1, 2021

Last Updated

January 18, 2023

Record last verified: 2023-01

Data Sharing

IPD Sharing
Will not share

Locations